Hydroxyzine Administration for Anxiety
For generalized anxiety disorder in adults, hydroxyzine should be administered orally at 50 mg daily, typically divided as 12.5 mg in the morning, 12.5 mg at midday, and 25 mg in the evening. 1, 2
Standard Dosing Protocol
The FDA-approved indication for hydroxyzine includes symptomatic relief of anxiety and tension associated with psychoneurosis 1. Based on multiple controlled trials demonstrating efficacy:
- Starting dose: 50 mg/day divided into three doses (12.5 mg morning, 12.5 mg midday, 25 mg evening) 2, 3
- Alternative single dosing: Some protocols use 25-50 mg as a single bedtime dose when sedation is desired 4
- Duration: Effectiveness beyond 4 months has not been systematically assessed; the physician should periodically reassess usefulness 1
Evidence Base
Research demonstrates hydroxyzine's anxiolytic efficacy begins within the first week of treatment. In a 3-month double-blind trial of 334 GAD patients, hydroxyzine 50 mg/day showed statistically significant improvement in Hamilton Anxiety Scale scores compared to placebo (-12.16 vs -9.64, p=0.019), with comparable efficacy to bromazepam 6 mg/day 2. A 4-week multicenter trial confirmed superiority over placebo on all anxiety measures from week one, with maintained efficacy after abrupt discontinuation without rebound anxiety 5.
Special Population Adjustments
Elderly patients: Start at the low end of the dosing range due to increased sensitivity to psychomotor impairment and anticholinergic effects. Sedating drugs may cause confusion and oversedation in this population 1.
Renal impairment: Use caution in dose selection, though the extent of renal excretion has not been fully determined 1.
Critical Safety Considerations
QT prolongation risk: Hydroxyzine carries risk of QT prolongation and Torsade de Pointes, particularly in patients with:
- Pre-existing heart disease
- Electrolyte imbalances
- Concomitant use of other QT-prolonging drugs (Class IA/III antiarrhythmics, certain antipsychotics, SSRIs like citalopram/fluoxetine, macrolide antibiotics) 1
CNS depression: The potentiating action with other CNS depressants (narcotics, barbiturates, alcohol) requires dosage reduction of concomitant agents 1. Patients must be warned against driving or operating machinery, as performance impairment can occur without subjective awareness of drowsiness 6.
Drug interactions: Avoid combining with MAOIs. Exercise caution with drugs metabolized by CYP450 enzymes 1.
Common Adverse Effects
The most frequent side effect is transient drowsiness (28% vs 14% placebo), which typically appears during the first week and progressively diminishes 5. Other effects include:
- Dry mouth (14% vs 5% placebo)
- Weight gain (12% vs 10% placebo)
- Loss of concentration (9% vs 8% placebo) 5
Rare but serious: Acute Generalized Exanthematous Pustulosis (AGEP) - discontinue immediately if skin rash develops 1.
Clinical Pearls
Hydroxyzine demonstrates particular efficacy for the somatic component of anxiety 7. Unlike benzodiazepines, it shows no evidence of dependency or withdrawal symptoms after abrupt discontinuation 8, 5. The antihistamine mechanism provides an alternative to benzodiazepine prescription, which may be advantageous in patients at risk for substance use disorders 2.
Contraindication to note: Avoid cetirizine or levocetirizine in patients who have experienced hypersensitivity reactions with hydroxyzine due to cross-sensitivity risk 1.